TNF and type 1 diabetes mellitus: In the context of immunotherapy of diabetes, TNF-alpha is a rational target not only because is cytotoxic to pancreatic beta cells [4,7], but also because some studies have found high levels of this cytokine compared to controls in subjects in whom had been recently diagnosed with T1DM [4].